M&T Bank Corp Sells 10,398 Shares of UnitedHealth Group Incorporated (NYSE:UNH)

M&T Bank Corp lowered its holdings in UnitedHealth Group Incorporated (NYSE:UNH) by 4.8% during the 4th quarter, Holdings Channel reports. The firm owned 205,089 shares of the healthcare conglomerate’s stock after selling 10,398 shares during the period. M&T Bank Corp’s holdings in UnitedHealth Group were worth $107,973,000 as of its most recent filing with the Securities and Exchange Commission.

Several other large investors have also recently made changes to their positions in UNH. Bensler LLC raised its position in UnitedHealth Group by 0.3% in the third quarter. Bensler LLC now owns 7,293 shares of the healthcare conglomerate’s stock worth $3,677,000 after acquiring an additional 19 shares during the period. Texas Capital Bancshares Inc TX raised its holdings in shares of UnitedHealth Group by 1.1% in the 3rd quarter. Texas Capital Bancshares Inc TX now owns 1,695 shares of the healthcare conglomerate’s stock worth $855,000 after purchasing an additional 19 shares during the period. Tealwood Asset Management Inc. grew its holdings in UnitedHealth Group by 0.4% during the fourth quarter. Tealwood Asset Management Inc. now owns 4,988 shares of the healthcare conglomerate’s stock valued at $2,626,000 after purchasing an additional 19 shares during the period. Atlas Private Wealth Advisors lifted its position in shares of UnitedHealth Group by 1.1% during the 4th quarter. Atlas Private Wealth Advisors now owns 1,752 shares of the healthcare conglomerate’s stock valued at $923,000 after buying an additional 19 shares during the last quarter. Finally, Prentice Wealth Management LLC increased its holdings in UnitedHealth Group by 0.8% in the 4th quarter. Prentice Wealth Management LLC now owns 2,347 shares of the healthcare conglomerate’s stock worth $1,235,000 after acquiring an additional 19 shares during the last quarter. 87.86% of the stock is owned by hedge funds and other institutional investors.

UnitedHealth Group Price Performance

NYSE UNH traded down $0.52 on Friday, reaching $492.45. 2,487,811 shares of the company’s stock traded hands, compared to its average volume of 5,130,659. The stock has a market cap of $453.09 billion, a PE ratio of 30.10, a P/E/G ratio of 1.43 and a beta of 0.55. The company has a debt-to-equity ratio of 0.69, a current ratio of 0.85 and a quick ratio of 0.79. UnitedHealth Group Incorporated has a 12 month low of $436.38 and a 12 month high of $554.70. The stock has a 50-day simple moving average of $482.32 and a 200 day simple moving average of $512.76.

UnitedHealth Group (NYSE:UNH) last posted its quarterly earnings results on Tuesday, April 16th. The healthcare conglomerate reported $6.91 earnings per share for the quarter, topping the consensus estimate of $6.63 by $0.28. UnitedHealth Group had a net margin of 4.05% and a return on equity of 26.50%. The business had revenue of $99.80 billion during the quarter, compared to the consensus estimate of $99.23 billion. During the same period in the previous year, the firm posted $6.26 earnings per share. The firm’s revenue for the quarter was up 8.6% on a year-over-year basis. As a group, research analysts predict that UnitedHealth Group Incorporated will post 27.6 earnings per share for the current year.

UnitedHealth Group Dividend Announcement

The company also recently announced a quarterly dividend, which was paid on Tuesday, March 19th. Stockholders of record on Monday, March 11th were issued a $1.88 dividend. This represents a $7.52 annualized dividend and a dividend yield of 1.53%. The ex-dividend date of this dividend was Friday, March 8th. UnitedHealth Group’s dividend payout ratio is 45.97%.

Insider Buying and Selling at UnitedHealth Group

In other news, EVP Erin Mcsweeney sold 1,236 shares of the company’s stock in a transaction dated Friday, March 8th. The shares were sold at an average price of $483.48, for a total transaction of $597,581.28. Following the completion of the transaction, the executive vice president now directly owns 9,364 shares of the company’s stock, valued at $4,527,306.72. The sale was disclosed in a legal filing with the SEC, which is accessible through this hyperlink. In related news, EVP Erin Mcsweeney sold 1,236 shares of the company’s stock in a transaction that occurred on Friday, March 8th. The stock was sold at an average price of $483.48, for a total transaction of $597,581.28. Following the completion of the transaction, the executive vice president now owns 9,364 shares in the company, valued at $4,527,306.72. The sale was disclosed in a filing with the SEC, which is available through this hyperlink. Also, CAO Thomas E. Roos sold 858 shares of the business’s stock in a transaction on Friday, February 23rd. The shares were sold at an average price of $525.79, for a total transaction of $451,127.82. Following the transaction, the chief accounting officer now directly owns 32,289 shares in the company, valued at $16,977,233.31. The disclosure for this sale can be found here. 0.35% of the stock is currently owned by corporate insiders.

Wall Street Analyst Weigh In

Several equities analysts have recently weighed in on UNH shares. TD Cowen reduced their target price on shares of UnitedHealth Group from $607.00 to $546.00 and set a “buy” rating for the company in a research note on Wednesday, April 10th. Truist Financial reissued a “buy” rating and set a $600.00 target price on shares of UnitedHealth Group in a report on Wednesday, April 17th. Erste Group Bank reiterated a “hold” rating on shares of UnitedHealth Group in a research note on Wednesday, March 13th. Stephens reaffirmed an “overweight” rating and set a $605.00 target price on shares of UnitedHealth Group in a report on Thursday, February 8th. Finally, Cantor Fitzgerald restated an “overweight” rating and issued a $591.00 price objective on shares of UnitedHealth Group in a research report on Wednesday, April 10th. Four research analysts have rated the stock with a hold rating and fifteen have assigned a buy rating to the stock. Based on data from MarketBeat.com, the stock presently has a consensus rating of “Moderate Buy” and a consensus target price of $570.05.

UnitedHealth Group Profile

UnitedHealth Group Incorporated operates as a diversified health care company in the United States. The company operates through four segments: UnitedHealthcare, Optum Health, Optum Insight, and Optum Rx. The UnitedHealthcare segment offers consumer-oriented health benefit plans and services for national employers, public sector employers, mid-sized employers, small businesses, and individuals; health care coverage, and health and well-being services to individuals age 50 and older addressing their needs; Medicaid plans, children's health insurance and health care programs; and health and dental benefits, and hospital and clinical services, as well as health care benefits products and services to state programs caring for the economically disadvantaged, medically underserved, and those without the benefit of employer-funded health care coverage.